Furthermore, Sacks et al. [37] reported no changes with respect to IL-1β gene expression levels in SAT from 15 subjects with MetS with CAD versus controls, whereas our data (using a much larger sample size) showed an increased amount of IL-1β released from SAT and in plasma. This evidence concerns the gene IL1B and coronary artery disorder.